Pulmonary Function Testing for Neonatal Respiratory Disorders

(PUFFOR Trial)

TM
CP
Overseen ByColm P Travers, MD
Age: < 18
Sex: Any
Trial Phase: Academic
Sponsor: University of Alabama at Birmingham
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to understand lung function in newborns, both preterm and term, with and without lung problems. Researchers use a gentle, non-invasive method called non-invasive forced airway oscillometry to measure lung function. The study includes infants who are at least 22 weeks gestational age and have been breathing without a ventilator for at least 12 hours. By comparing lung function across different groups, researchers hope to gain insights into conditions like respiratory distress syndrome and other common newborn lung issues. Parents or legal guardians must consent for their infants to participate. As an unphased trial, this study offers a unique opportunity to contribute to important research that could improve care for newborns with lung issues.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

Will I have to stop taking my current medications?

The trial information does not specify whether participants need to stop taking their current medications.

What prior data suggests that non-invasive forced airway oscillometry is safe for neonatal pulmonary function testing?

Research has shown that non-invasive forced airway oscillometry safely checks lung function in newborns. This method uses gentle airwaves to assess a baby's lung performance. Being non-invasive, it avoids needles or surgery, ensuring comfort for infants.

No reports of harmful side effects have emerged from this technique. It has been successfully applied to both healthy newborns and those with breathing issues, offering valuable information without causing harm. This indicates that non-invasive forced airway oscillometry is well-tolerated and poses minimal risk to infants.12345

Why are researchers excited about this trial?

Researchers are excited about using non-invasive forced airway oscillometry for neonatal respiratory disorders because it offers a safer and less invasive way to assess lung function in infants. Unlike traditional methods, which often involve more invasive techniques like intubation or sedation, this approach uses gentle oscillations of air to measure lung function without causing discomfort or harm to the baby. This method allows for both cross-sectional and longitudinal analysis, which can provide a more comprehensive understanding of how lung function develops or deteriorates over time in various neonatal conditions. Ultimately, this technique could lead to better diagnosis and monitoring of respiratory disorders in newborns, potentially improving outcomes for these vulnerable patients.

What evidence suggests that non-invasive forced airway oscillometry is effective for measuring pulmonary function in neonatal respiratory disorders?

Research has shown that non-invasive forced airway oscillometry, studied in this trial, effectively checks lung function in newborns. This technique distinguishes between healthy babies and those with conditions like transient tachypnea of the newborn (TTN) on their first day. Being non-invasive, it avoids needles or surgery, making it ideal for infants. Studies have found that this method provides important information about lung health and can monitor changes over time. This makes it a promising tool for understanding and managing breathing problems in newborns.12567

Who Is on the Research Team?

NA

Namasivayam Ambalavanan, MD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for infants born at or after 22 weeks of gestation who are off ventilators for at least 12 hours. It's open to those whose parents or guardians consent, but not to babies with terminal illnesses, neuromuscular conditions affecting breathing, major malformations, or if there's a decision to limit support.

Inclusion Criteria

My infant has been off a ventilator or CPAP for at least 12 hours.
My child's legal guardians have agreed to the study.
My baby was born at or after 22 weeks of pregnancy.

Exclusion Criteria

My infant has a significant birth defect.
A decision has been made to limit or not provide further treatment for my infant.
My infant has a condition that impacts their breathing.
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Observation

Lung function is measured using non-invasive forced oscillometry in term and preterm infants with and without lung disease.

40 weeks' postmenstrual age or until discharge

Follow-up

Participants are monitored for changes in lung function and response to therapeutic interventions.

Up to 2 years

What Are the Treatments Tested in This Trial?

Interventions

  • Non-invasive forced airway oscillometry
Trial Overview The study observes lung function in newborns using non-invasive forced oscillometry. It aims to understand respiratory health in term and preterm infants with various lung diseases and how they respond to treatments without the need for invasive procedures.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Non-invasive forced airway oscillometryExperimental Treatment1 Intervention

Non-invasive forced airway oscillometry is already approved in European Union, United States, Canada for the following indications:

🇪🇺
Approved in European Union as Non-invasive forced oscillometry for:
🇺🇸
Approved in United States as Forced oscillation technique for:
🇨🇦
Approved in Canada as Impulse oscillometry for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Published Research Related to This Trial

Pulmonary function testing is crucial for diagnosing and managing respiratory insufficiency in critically ill neonates, allowing for better prognosis and tailored therapy.
Recent advancements in technology enable quick and accurate bedside assessments of neonatal pulmonary function, emphasizing the important role of intensive care nurses in obtaining reliable data to inform care plans.
Pulmonary function testing in the critically ill neonate, Part I: An overview.Greenspan, JS., Cullen, JA., Zukowsky, K., et al.[2004]
Pulmonary function testing in neonates is a crucial, low-risk diagnostic tool that helps monitor lung disease progression and assess responses to treatments like surfactant therapy, and it can be performed at the bedside in under 60 minutes.
These tests provide immediate results that can guide nursing care, measuring important pulmonary 'vital signs' such as tidal volume and respiratory rate, and can be conducted on infants regardless of their ventilation status.
Pulmonary function testing in the critically ill neonate, Part II: Methodology.Cullen, JA., Greenspan, JS., Antunes, MJ., et al.[2004]
Respiratory oscillometry is a valuable pulmonary function test that can be performed with minimal patient cooperation, making it suitable for young children and those unable to perform traditional spirometry due to cognitive or physical limitations.
After implementing a formal training program and standard operating protocol for respiratory oscillometry, there was a significant improvement in the quality of tests, leading to more acceptable and reproducible measurements, which is crucial for accurate lung function assessment.
Conducting Respiratory Oscillometry in an Outpatient Setting.Chang, E., Vasileva, A., Nohra, C., et al.[2023]

Citations

Non-invasive Forced Oscillometry to Quantify Respiratory ...FOT is feasible in neonates and distinguishes normal control infants from those with TTN on postnatal day 1. Oscillometry offers a non-invasive, longitudinal ...
2.pubmed.ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov/31935746/
Non-invasive forced oscillometry to quantify respiratory ...Oscillometry offers a non-invasive, longitudinal technique to assess lung mechanics in newborns ... To determine normative data by forced oscillation technique ( ...
Pulmonary Function Using Non-invasive Forced OscillometryThe purpose of this observational study is to measure pulmonary function in term and preterm infants with and without pulmonary disease ...
Forced Oscillometry in Infants with Bronchopulmonary Dysp...The forced oscillation technique (FOT) is a non-invasive method that had been used to measure respiratory mechanics. FOT employs small amplitude ...
Noninvasive Monitoring Strategies for Bronchopulmonary ...The interruption technique, forced oscillation technique, and pulse oscillometry for the study of resistances and reactances could be implemented. Other serial ...
Respiratory Oscillometry in Newborn Infants: Conventional ...Respiratory oscillometry measures the mechanical impedance of the respiratory system (Zrs), and it has been shown as a promising method in different ...
The forced oscillation technique in clinical practiceThe forced oscillation technique (FOT) is a noninvasive method with which to measure respiratory mechanics. FOT employs small-amplitude pressure oscillations ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security